The role of mitomycin antibiotics in the chemotherapy of solid tumors.
A C
AC
Sartorelli
D000693:Anaerobiosis; D000818:Animals; D001711:Biotransformation; D003580:Cytochromes / Q000378:metabolism; D001728:Dicumarol / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D016685:Mitomycin; D008937:Mitomycins / Q000378:metabolism / Q000627:therapeutic use*; D016660:NAD(P)H Dehydrogenase (Quinone); D009374:Neoplasms, Experimental / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism; D011160:Porfiromycin / Q000378:metabolism / Q000627:therapeutic use; D011808:Quinone Reductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000378:metabolism
D003580:Cytochromes; D008937:Mitomycins; D016685:Mitomycin; D001728:Dicumarol; D016660:NAD(P)H Dehydrogenase (Quinone); D011808:Quinone Reductases; D011160:Porfiromycin